C Dong, J Wu, Y Chen, J Nie, C Chen - Frontiers in pharmacology, 2021 - frontiersin.org
Although chemotherapy, targeted therapy and endocrine therapy decrease rate of disease recurrence in most breast cancer patients, many patients exhibit acquired resistance …
Abstract P-glycoprotein (P-gp) is a drug efflux transporter that triggers doxorubicin (DOX) resistance. In this review, we highlight the molecular avenues regulating P-gp, such as Nrf2 …
H Zhang, H Xu, CR Ashby Jr, YG Assaraf… - Medicinal research …, 2021 - Wiley Online Library
Multidrug resistance (MDR) remains one of the major impediments for efficacious cancer chemotherapy. Increased efflux of multiple chemotherapeutic drugs by transmembrane ATP …
A Kumar, V Jaitak - European journal of medicinal chemistry, 2019 - Elsevier
Cancer is a prominent cause of death globally. Currently, many drugs that are in clinical practice are having a high prevalence of side effect and multidrug resistance. Risk of tumors …
J Chandra, N Hasan, N Nasir, S Wahab… - Environmental …, 2023 - Elsevier
In current scenario skin cancer is a serious condition that has a significant impact on world health. Skin cancer is divided into two categories: melanoma skin cancer (MSC) and non …
L Bayón-Cordero, I Alkorta, L Arana - Nanomaterials, 2019 - mdpi.com
Drug delivery systems have opened new avenues to improve the therapeutic effects of already-efficient molecules. Particularly, Solid Lipid Nanoparticles (SLNs) have emerged as …
NH Khan, M Mir, L Qian, M Baloch, MFA Khan… - Journal of Advanced …, 2022 - Elsevier
Background Skin cancer has been the leading type of cancer worldwide. Melanoma and non-melanoma skin cancers are now the most common types of skin cancer that have been …
CM Mckertish, V Kayser - Biomedicines, 2021 - mdpi.com
The popularity of antibody drug conjugates (ADCs) has increased in recent years, mainly due to their unrivalled efficacy and specificity over chemotherapy agents. The success of the …
N Feng, Y Liu, X Dai, Y Wang, Q Guo, Q Li - RSC advances, 2022 - pubs.rsc.org
Cerium oxide nanozymes have emerged as a new type of bio-antioxidants in recent years. CeO2 nanozymes possess enzyme mimetic activities with outstanding free radical …